Jefferies analyst Nalin Tejavibulya lowered the price target on 4D Molecular Therapeutics (NASDAQ: FDMT) to $40.00 (from $51.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE